Rituximab Maintenance for Follicular Lymphoma CAR-T Trial salvages Primary, Refractory, or those who failed initial therapy - 100459

Spotlight
Video

Rituximab Maintenance for Follicular Lymphoma CAR-T Trial salvages Primary, Refractory, or those who failed initial therapy

moasc has 295 videos Subscribe Here

Loading........
Description: Elizabeth Brém, MD - HS Clinical Assistant Professor Chao Comprehensive Cancer Center discusses Rituximab Maintenance for Follicular Lymphoma CAR-T Trial salvages Primary, Refractory, or those who failed initial therapyat MOASC’s Spotlight On Hematology in Huntington Beach 2018.
Shared By : moasc
Posted on : 02/06/18
Added : 3 months ago
Category : Lymphoma



Recommended

Nothing found.